BioCentury | Mar 16, 2021
Deals

March 15 Quick Takes: Canada’s CPP leads insitro’s $400M series C; plus Bicara, Aveo, Gilead-Merck and more

...By BioCentury Staff Insitro Inc. said existing investor Canada Pension Plan Investment Board led its new $400 million series C...
BioCentury | Jan 13, 2021
Finance

IPO filing reveals details of Sana’s deep pipeline, aggregation of next-generation gene and cell therapy technologies

...firm’s Robert Nelsen holds a board seat. After Flagship, the next largest institutional holders are the Canada Pension Plan Investment Board...
BioCentury | Nov 19, 2020
Finance

Nov. 18 Quick Takes: Venture rounds for Elevation, Pharvaris as Kodiak follow-on brings in $560M; plus AbCellera takes out Trianni for $90M and more

...the equivalent of 3.3 million ADSs, with each ADS representing five shares, at $30 to Canada Pension Plan Investment Board...
BioCentury | Jun 26, 2020
Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

...Fusion’s shareholders include HealthCap, Adams Street Partners, Varian Medical Systems, Johnson & Johnson (NYSE:JNJ), the Canada Pension Plan Investment Board...
BioCentury | Jun 25, 2020
Emerging Company Profile

Sana’s quest to usher in next generation of cell, gene therapies

...it had drawn down all of the money. Investors include Arch Venture Partners, Flagship Pioneering, Canada Pension Plan Investment Board...
...of employees: 230 Funds raised: More than $700 million Investors: Arch Venture Partners, Flagship Pioneering, Canada Pension Plan Investment Board...
BioCentury | May 26, 2020
Finance

insitro to translate $143 million B round into drug discovery platform

...data into therapeutic programs (see “ insitro: Machine Learning with Designated Data ”). New investors Canada Pension Plan Investment Board...
BioCentury | May 7, 2020
Finance

May 6 Quick Takes: Grail raises year’s largest venture round; plus fresh funds for Insmed, Kura, TG, BerGenBio, Limbix and Kineta

...year's largest venture round to date. New backers, including Public Sector Pension Investment Board and Canada Pension Plan Investment Board...
BioCentury | Mar 17, 2020
Finance

Sigilon nears first clinical test of cell shielding tech with $80M series B

...shielded cell therapies into the clinic, while also advancing toward INDs on four other programs. Canada Pension Plan Investment Board...
BioCentury | Feb 18, 2020
Finance

Canada’s Sagard gaining healthcare foothold via royalty fund

...investment strategy.” David MacNaughtan, Sagard Before joining Sagard, MacNaughtan was a senior principal with the Canada Pension Plan Investment Board...
BioCentury | May 20, 2019
Company News

May 20 Company Quick Takes: LifeArc trades Keytruda royalties for $1.3B; plus Evotec-Just, Actelion-Owlstone, Genomind

...sold an undisclosed portion of its royalties for Keytruda pembrolizumab to a subsidiary of the Canada Pension Plan Investment Board...
Items per page:
1 - 10 of 14
BioCentury | Mar 16, 2021
Deals

March 15 Quick Takes: Canada’s CPP leads insitro’s $400M series C; plus Bicara, Aveo, Gilead-Merck and more

...By BioCentury Staff Insitro Inc. said existing investor Canada Pension Plan Investment Board led its new $400 million series C...
BioCentury | Jan 13, 2021
Finance

IPO filing reveals details of Sana’s deep pipeline, aggregation of next-generation gene and cell therapy technologies

...firm’s Robert Nelsen holds a board seat. After Flagship, the next largest institutional holders are the Canada Pension Plan Investment Board...
BioCentury | Nov 19, 2020
Finance

Nov. 18 Quick Takes: Venture rounds for Elevation, Pharvaris as Kodiak follow-on brings in $560M; plus AbCellera takes out Trianni for $90M and more

...the equivalent of 3.3 million ADSs, with each ADS representing five shares, at $30 to Canada Pension Plan Investment Board...
BioCentury | Jun 26, 2020
Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

...Fusion’s shareholders include HealthCap, Adams Street Partners, Varian Medical Systems, Johnson & Johnson (NYSE:JNJ), the Canada Pension Plan Investment Board...
BioCentury | Jun 25, 2020
Emerging Company Profile

Sana’s quest to usher in next generation of cell, gene therapies

...it had drawn down all of the money. Investors include Arch Venture Partners, Flagship Pioneering, Canada Pension Plan Investment Board...
...of employees: 230 Funds raised: More than $700 million Investors: Arch Venture Partners, Flagship Pioneering, Canada Pension Plan Investment Board...
BioCentury | May 26, 2020
Finance

insitro to translate $143 million B round into drug discovery platform

...data into therapeutic programs (see “ insitro: Machine Learning with Designated Data ”). New investors Canada Pension Plan Investment Board...
BioCentury | May 7, 2020
Finance

May 6 Quick Takes: Grail raises year’s largest venture round; plus fresh funds for Insmed, Kura, TG, BerGenBio, Limbix and Kineta

...year's largest venture round to date. New backers, including Public Sector Pension Investment Board and Canada Pension Plan Investment Board...
BioCentury | Mar 17, 2020
Finance

Sigilon nears first clinical test of cell shielding tech with $80M series B

...shielded cell therapies into the clinic, while also advancing toward INDs on four other programs. Canada Pension Plan Investment Board...
BioCentury | Feb 18, 2020
Finance

Canada’s Sagard gaining healthcare foothold via royalty fund

...investment strategy.” David MacNaughtan, Sagard Before joining Sagard, MacNaughtan was a senior principal with the Canada Pension Plan Investment Board...
BioCentury | May 20, 2019
Company News

May 20 Company Quick Takes: LifeArc trades Keytruda royalties for $1.3B; plus Evotec-Just, Actelion-Owlstone, Genomind

...sold an undisclosed portion of its royalties for Keytruda pembrolizumab to a subsidiary of the Canada Pension Plan Investment Board...
Items per page:
1 - 10 of 14